Korey Tascilar

32PUBLICATIONS
122CO-AUTHORS
AutoimmunityAllergyRheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 29, 2026
Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity.

|Mar 23, 2026
Increased synovial and entheseal fibroblast activation detected by 68Ga-FAPI-PET/CT is associated with the development of psoriatic arthritis in psoriasis patients with arthralgia.

Giulia Corte, Armin Atzinger, Rita Noversa de Sousa

|Feb 25, 2026
Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study.

Louis Schuster, Alp Temiz, Melek Yalcin Mutlu

|Jan 07, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

Fabian Müller, Melanie Hagen, Andreas Wirsching

|Dec 17, 2025
Comparison of long-term efficacy, tolerability and drug survival rates of baricitinib as monotherapy or combination therapy in RA patients: data from a real-world prospective cohort study.

Alp Temiz, Koray Tascilar, Arnd Kleyer

|Nov 28, 2025
Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing disease.

Armin Atzinger, Koray Tascilar, Arnd Kleyer

Pageof 6

Frequent Collaborators

13 joint publications

David Simon

12 joint publications

Georg Schett

10 joint publications

Arnd Kleyer

9 joint publications

Filippo Fagni